MTOR and neoplasm: Table 2 outlines how the activation of the mTOR pathway, either by oncogene stimulation or the loss of tumour suppressors can lead to the development of tumour angiogenesis and metastasis in various in-vitro cell lines and in-vivo mouse xenograft models [56].